Skip to main content

Table 3 Hemodynamic parameters at pre-occlusion, pre-administration and post-administration (180 min)

From: Protective effect of Suxiao jiuxin pill, a traditional Chinese medicine, against acute myocardial ischemia in dogs

Time

Parameters

HR

MAP

LVSP

LVEDP

+dP/dtmax

-dP/dtmix

CBF

MBF

CVR

bpm

mmHg

mmHg

mmHg

mmHg/s

mmHg/s

ml/min

ml/min.100 g

mmHg.min/mL

Pre-Occ

 Sham

175.35 ± 31.3

119.18 ± 14.43

147.27 ± 23.14

4.89 ± 3.36

3050.63 ± 542.34

−2610.66 ± 670.12

45.19 ± 2.41

161.31 ± 32.34

0.74 ± 0.09

 Model

170.03 ± 35.3

123.88 ± 14.1

149.15 ± 13.74

3.45 ± 8.2

2850.71 ± 600.93

−2587.09 ± 477.81

47.86 ± 8.87

182.79 ± 60.94

0.79 ± 0.23

 SX-H

167.88 ± 23.46

106.99 ± 21.01

135.26 ± 26.29

4.6 ± 4.2

2987.07 ± 825.57

−2329.83 ± 731.73

45.89 ± 7.32

163.02 ± 32.79

0.78 ± 0.21

 SX-M

171.5 ± 25.06

106.92 ± 15.12

139.34 ± 7.64

3.68 ± 3.33

2764.46 ± 355

−2426.34 ± 459.77

44.05 ± 6.15

172.57 ± 43.87

0.76 ± 0.24

 SX-L

167.4 ± 24.96

113.47 ± 16.49

136.85 ± 17.57

5.1 ± 2.21

2785.09 ± 635.7

−2533.04 ± 765.36

46.07 ± 13.52

145.87 ± 50.5

0.82 ± 0.25

 ISD

171.16 ± 18.55

118.1 ± 20.7

146.88 ± 24.73

4.94 ± 1.9

2797.02 ± 481.73

−2328 ± 542.84

46.84 ± 2.81

185.2 ± 50.47

0.72 ± 0.18

Pre-Adm

 Sham

175.97 ± 27.68

121.45 ± 16.64

149.37 ± 25.47

5.15 ± 0.53

3222.04 ± 595.88

−2720.74 ± 912.21

49.28 ± 7.95

171.94 ± 12.13

0.71 ± 0.09

 Model

163.34 ± 33.96

104.26 ± 1.6

134.8 ± 10.66

7.69 ± 3.1

2445.67 ± 343.97

−2416.3 ± 310.43

44.64 ± 10.78

179.61 ± 55.94

0.74 ± 0.19

 SX-H

160.02 ± 23.66

97.23 ± 18.85

131.07 ± 22.75

7.74 ± 3.25

2234.54 ± 642.44

−2110.49 ± 636.37

40.79 ± 8.1

149.81 ± 28.52

0.67 ± 0.19

 SX-M

172.79 ± 26.4

102.51 ± 19.92

133.58 ± 9.97

6.81 ± 2.39

2549.35 ± 364.23

−2373.87 ± 334.64

44.68 ± 10.48

174.87 ± 58.35

0.65 ± 0.22

 SX-L

165.27 ± 23.43

103.91 ± 15.53

125.56 ± 14.96

8.1 ± 3.1

2437.5 ± 482.9

−2308.27 ± 542.33

44.02 ± 12.37

137.31 ± 34.7

0.75 ± 0.18

 ISD

165.43 ± 20.48

101.5 ± 23.81

112.53 ± 11.88

8.91 ± 1.35

2235.42 ± 509.53

−2037.27 ± 511.09

46.67 ± 10.35

175.73 ± 77.42

0.70 ± 0.16

Post-Adm

 Sham

176.98 ± 33.58

111.3 ± 18.19

133.38 ± 18.78

4.7 ± 2.6

2830.94 ± 814

−2595.17 ± 718.67

50.37 ± 10.36

174.92 ± 18.42

0.68 ± 0.1

 Model

168.9 ± 38.59

95.3 ± 12.26

132.34 ± 9.95

8.94 ± 1.87

1873.17 ± 532.67

−2120.28 ± 544.01

33.15 ± 9.75&

126.63 ± 27.83&

0.82 ± 0.19&

 SX-H

184.27 ± 37.12

80.96 ± 5.29*

96.57 ± 12.05**&&

5.82 ± 2.65*&

1835.97 ± 141.59

−1862.88 ± 265.58

58.86 ± 13.3**&

219 ± 64.55*&&

0.36 ± 0.09**&&

 SX-M

186.38 ± 36.32

90.9 ± 16.36

97.23 ± 22.2**&&

5.5 ± 3.05*

1946.72 ± 380.59

−1939.73 ± 720.86

49.66 ± 8.29*

205.25 ± 74.85*&&

0.48 ± 0.21*&

 SX-L

174.25 ± 20.49

96.5 ± 17.19

109.33 ± 14.06**

6.09 ± 3.2*

2183.55 ± 423.96

−2081.71 ± 441.56

52.13 ± 13.41*

180.23 ± 53.75*&

0.55 ± 0.31&

 ISD

167.28 ± 22.23

82.03 ± 2.51*

113.51 ± 6.79**

6.41 ± 3.19*&

2008.15 ± 175.04

−2024.36 ± 265.35

61 ± 13.55**&

222.55 ± 93.78*&&

0.4 ± 0.15**&&

  1. All data were expressed as mean ± S.D. HR heart rate, MAP mean arterial pressure, LVSP left ventricular systolic pressure, LVEDP left ventricular end-diastolic pressure, +dP/dtmax maximal positive left ventricular dP/dt, -dP/dtmix minimal positive left ventricular dP/dt, CBF coronary blood flow, MBF myocardial blood flow, CVR coronary vascular resistance. *P < 0.05, **P < 0.01 vs. model group; & P < 0.05, && P < 0.01 vs. Pre-Adm